Package 51672-4172-1

{"route": ["ORAL"], "spl_id": "ff558824-b008-4b94-8aa5-d7818bc27a4f", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["X72RBB02N8"], "rxcui": ["310285"], "spl_set_id": ["0afffb17-e6ac-4bea-a90e-7ef3c8150290"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "237 mL in 1 BOTTLE (51672-4172-1)", "package_ndc": "51672-4172-1", "marketing_start_date": "20170616"}, {"sample": false, "description": "473 mL in 1 BOTTLE (51672-4172-9)", "package_ndc": "51672-4172-9", "marketing_start_date": "20170616"}], "brand_name": "Felbamate", "product_id": "51672-4172_ff558824-b008-4b94-8aa5-d7818bc27a4f", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-4172", "generic_name": "Felbamate", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Felbamate", "active_ingredients": [{"name": "FELBAMATE", "strength": "600 mg/5mL"}], "application_number": "ANDA206314", "marketing_category": "ANDA", "marketing_start_date": "20170616", "listing_expiration_date": "20261231"}